Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
Is a |
Pseudoephedrine compound product |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
Is a |
Product containing codeine phosphate |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
Is a |
Product containing triprolidine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Codeine phosphate |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Codeine (substance) |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pseudoephedrine hydrochloride |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Morphinan opioid |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Triprolidine hydrochloride |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Some |
|
|
Codeine phosphate + pseudoephedrine hydrochloride + triprolidine hydrochloride |
Is a |
Product containing pseudoephedrine (medicinal product) |
false |
Inferred relationship |
Some |
|
|